Adults with type 2 diabetes and overweight or obesity who use a GLP-1 receptor agonist have similar risk for kidney cancer as ...

Clinically meaningful MG-ADL response (≥2-point reduction) occurred in 69% of treated patients, exceeding the 53% response ...

DEEP DIVE ANALYSIS: Visit Hagens Berman's dedicated QURE case page: www.hbsslaw.com/cases/uniqure, or view our latest video summary of the allegations: https://youtu.be/VWKl1BzabcE On March 5 and 6, ...

It is a running gag around here that whenever a project posts, someone will inevitably point out that it could have been done ...

Background Estimates indicate that 45% of mortality among children under 5-year old is linked to nutrition. Increased food ...

Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...

At ACC, tonlamarsen reduced angiotensinogen in a trial, but the data raise questions about its duration and how well it can treat hypertension.

Abstract: In this work, we propose a novel comparator-less piecewise linear approximate computation (CL-PLAC) method with hardware-software co-optimization schemes for a cost-effective implementation ...

Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...

Medicare Part D’s 2024 redesign—catastrophic coinsurance removal and expanded full LIS eligibility—was associated with a 4.9-PP decline in cost-related nonadherence versus privately insured ...